1Pulsinelli WA, Jacewicz M, Levy DE, et al. Ischemic brain injury and the therapeutic window. Ann N Y Acad Sci, 1997, 835: 187-193.
2Horn M, Scholte W. Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia. Acta Neuropathol (Berl), 1995,85(1): 79-87.
4Jones TH, Morawetz RB, Crowell RM, et al. Thresholds of focal cerebral ischemia in awake monkeys. J Neurosurg, 1981,54(6):773-782.
5Heiss WD, Graf R. The ischemic penumbra. Curr Opin Neurol,1994, 7(1): 11-19
6Hossmann KA. Viability thresholds and the penumbra of focalischemia. Ann Neurol, 1994, 36(4): 557-565.
7Heiss WD, Thiel A, Grond M, et al. Which targets are relevant for therapy of acute ischemic stroke? Stroke, 1999, 30(7): 1486-1489.
8Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet, 1998, 352 (9136):1245-1251.
9Adams HP Jr, Brott TG, Furlan AJ, et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation, 1996, 94 (5):1167-1174.
10von Kummer R, Allen KL, Holle R, et al. Acute stroke: usefulness of early CT findings before thrombolytic therapy. Radiology, 1997, 205(2): 327-333.
